Rossi R, Assad G Bani, Buggiani G, Lotti T
University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, Italy.
Dermatol Ther. 2008 Sep-Oct;21(5):412-5. doi: 10.1111/j.1529-8019.2008.00224.x.
The major therapeutic approaches (5-fluorouracil, imiquimod, vermilionectomy, and CO(2) Laser ablation) for actinic cheilitis are aimed at avoiding and preventing a malignant transformation into invasive squamous cell carcinoma via destruction/removal of the damaged epithelium. Recently, photodynamic therapy (PDT) has been introduced as a therapeutic modality for epithelial skin tumors, with good efficacy/safety profile and good cosmetic results. Regarding actinic cheilitis, PDT could be considered a new therapeutic option? The target of our study was to evaluate the efficacy and tolerability of PDT in actinic cheilitis, using a methyl-ester of aminolevulinic acid (MAL) as topical photosensitizing agent and controlled the effects of the therapy for a 30-month follow-up period. MAL-PDT seems to be the ideal treatment for actinic cheilitis and other actinic keratosis, especially on exposed parts such as the face, joining tolerability and clinical efficacy with an excellent cosmetic outcome.
光化性唇炎的主要治疗方法(5-氟尿嘧啶、咪喹莫特、唇红切除术和二氧化碳激光消融)旨在通过破坏/去除受损上皮来避免和预防向浸润性鳞状细胞癌的恶性转化。最近,光动力疗法(PDT)已被引入作为上皮性皮肤肿瘤的一种治疗方式,具有良好的疗效/安全性和良好的美容效果。对于光化性唇炎,PDT能否被视为一种新的治疗选择?我们研究的目的是评估使用氨基乙酰丙酸甲酯(MAL)作为局部光敏剂的光动力疗法在光化性唇炎中的疗效和耐受性,并在30个月的随访期内控制该疗法的效果。MAL-PDT似乎是光化性唇炎和其他光化性角化病的理想治疗方法,尤其是在面部等暴露部位,它兼具耐受性和临床疗效,美容效果极佳。